MARISSA BRADLEY: Open Payments
NPI 1942885926 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 30 payments from 10 companies in 2025. Trend: 2023 $801 · 2024 $862 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 12 | $200 |
| Teva Pharmaceuticals USA, Inc. | 4 | $67 |
| Janssen Pharmaceuticals, Inc | 4 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Braeburn Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: SUBLOCADE, UZEDY, INVEGA SUSTENNA, CAPLYTA, Auvelity, BRIXADI, INGREZZA, ARISTADA.
Industry payments across OK — which companies pay providers there.
